Form 4 for CPIX CUMBERLAND PHARMACEUTICALS INC
Accepted 2022-04-29 00:00:00 ET · period of report 2022-03-17 · accession 0001209191-22-026154 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-04-29 | 2022-03-17 | CPIX | Cearnal Martin E | SVP, Chief Commercial Off, Dir | J - Other | $2.74 | -15.0K | 163.5K | -8% | -$41.1K |
| D | 2022-04-29 | 2022-03-17 | CPIX | Cearnal Martin E | SVP, Chief Commercial Off, Dir | J - Other | $0.00 | -5,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-17 | J | D | 15,000 | $2.74 | 163,473 | D | — | — | |
| 2 | Derivative | Options (right to buy) | 2022-03-17 | J | D | 5,000 | $0.00 | 0 | D | $3.22 · 2025-03-17 to 2031-03-17 | 5,000 Common Stock |